(Press-News.org) LA JOLLA, CA – April 11, 2013 – Scientists at The Scripps Research Institute (TSRI) have made a counterintuitive finding that may lead to new ways to clear persistent infection that is the hallmark of such diseases as AIDS, hepatitis B and hepatitis C.
The study, reported in the April 12, 2013 issue of the journal Science, focused on the activity of the body's type 1 interferon (IFN-I) proteins. Since its discovery over 50 years ago, IFN-I has been believed to be an especially powerful antiviral agent that marshals the immune system's response against the body's foreign invaders. But in the new study, the TSRI scientists document in mice that IFN-I initiates persistent infection and limits the generation of an effective antiviral immune response.
"Our findings illuminate an unexpected role for IFN-I protein(s) in persistent infections, which has major implications for how we treat these infections," said Michael B. A. Oldstone, a professor in the Department of Immunology and Microbial Science at TSRI and senior investigator for the study.
Mystery of Immune Suppression
For decades, Oldstone and other virologists around the world have been trying to understand how some viruses manage to persist in their hosts.
One big clue, discovered only in recent years, is that some of these viruses are especially effective at getting into cells of the immune system known as dendritic cells. These cells serve as key detectors of infection and normally respond to viral infection by producing IFN-I proteins. They also produce both immune-enhancing proteins (cytokines/chemokines) to drive forward a vigorous immune response, as well as immune-suppressing proteins including interleukin-10 (IL-10) and PD-1, which act as a braking system that balances the immune response to keep within healthy (non-autoimmune) limits.
Persistent viruses can use this immune-suppressing effect for their own purposes. In several experimental models of persistent infections and in humans with persistent infections, a rise in IL-10 and PD-L1 is followed by declines in the function and numbers of antiviral T-cells. Many of the surviving T cells are rendered ineffectual—a phenomenon called "T-cell exhaustion" or "hyporesponsiveness."
A Surprising Observation
To better understand how this immune-suppressing response develops, Oldstone and his team, including first authors John R. Teijaro and Cherie Ng, along with Brian Sullivan, looked in detail at the early events in a persistent viral infection. The team used a now-standard animal model that Oldstone developed almost 30 years ago: laboratory mice infected with lymphocytic choriomeningitis virus (LCMV) Clone (Cl) 13 strain.
One initial observation surprised them. "A day after infection, bloodstream levels of IFN-I were at least several times higher in the persistent infection, compared to a non-persistent LCMV infection," said Teijaro.
The persistent LCMV Cl 13 strain also turned out to be much better at infecting plasmacytoid dendritic cells—which are considered the principal source of IFN-I proteins during viral infections. By contrast, the LCMV Armstrong (ARM) 53b strain, from which Cl 13 was derived, generated significantly less IFN-I and did not induce a persistent infection but rather generated antiviral effector CD8 T cells; this infection was terminated within 7 to 10 days. Cl 13 differs from ARM by only three amino acids (protein building blocks) of which just two are important; one in the glycoprotein for binding and entry into dendritic cells and the other in the viral polymerase that enhances viral replication.
Earlier Clearance and Fewer Malfunctions
The production of IFN-Is by plasmacytoid dendritic cells has been considered a normal and beneficial part of the immune reaction to a viral infection. "We usually think of IFN-I proteins as antiviral proteins, so that more IFN is better," said Ng. Indeed, when she and Teijaro used a monoclonal antibody to block IFN-I-alpha-beta (-α-β) receptor, activity just prior to or after infection with Cl 13, they observed a sharp drop in the production of IL-10 and PD-L1, loss of excessive cytokine/chemokine expression (cytokine storm) and maintenance of normal secondary lymphoid tissue architecture.
But the scientists found over the longer term a sharp drop in levels of immune-suppressing IL-10, as well as PD-L1, both inducers of T-cell exhaustion, was associated with restoration of antiviral immune response and virus clearance. And although blocking the IFN-I-α-β receptor led to higher bloodstream levels of virus in the first days after infection, it soon brought about a stronger, infection-clearing response.
"Even when we blocked IFN-I-α-β receptor after a persistent infection had been established and T-cell exhaustion had set in, we still saw a significantly earlier clearance of the virus," Ng said.
Blocking IFN-I-α-β receptor also prevented or reversed other immune malfunctions caused by the persistent LCMV strain, including a disruption of the structure of the spleen tissue and diminished T cell entry and maintenance within lymphoid structures in the spleen that contain dendritic cells. The interaction of dendritic cells with T cells is necessary to generate antiviral effector CD8 and CD4 T cells. "We saw a restoration of this lymphoid architecture, as well as an increase in a subset of antiviral T cells, natural killer cells and dendritic cells, and restoration of antiviral CD4 T cell function," said Teijaro.
Potentially Broad Applications
Oldstone and his team now plan to study IFN-I signaling pathways in further detail. In particular, they hope to determine whether the IFN-I-α-β receptor blocking strategy can work against chronic viral infections in humans. The scientists will also seek small pharmacologic molecules with the same function.
"Most of our findings in the LCMV model mirror what has been observed in human persistent infections, namely the upregulation of IL-10 and PD-L1, and the disruption of lymphoid architecture," said Oldstone.
Conceivably, the IFN-I-α-β receptor-blocking strategy could have broad clinical applications. In terms of viruses alone, chronic HIV, hepatitis B and hepatitis C infections collectively are found in hundreds of millions of people worldwide. Other common persistent viruses include Epstein-Barr virus, cytomegalovirus and cancer-causing human papilloma virus. Researchers have estimated that the average person at any one time carries at least several persistent, often silent viral infections.
INFORMATION:
Other contributors to the study, "Persistent LCMV infection is controlled by blockade of type 1 interferon signaling," were Kathleen C. F. Sheehan and Robert D. Schreiber of Washington School of Medicine at St. Louis; and Megan J. Welch, Andrew M. Lee, and Juan Carlos de la Torre of TSRI.
The study was supported by the National Institutes of Health grants AI009484, AI057160 and AI077719, as well as an American Heart Association Fellowship (11POST7430106).
Study finds interferon, one of the body's proteins, induces persistent viral infection
The findings suggest a new approach to clearing infections from AIDS to hepatitis
2013-04-12
ELSE PRESS RELEASES FROM THIS DATE:
A bright idea: Tiny injectable LEDs help neuroscientists study the brain
2013-04-12
CHAMPAIGN, Ill. — A new class of tiny, injectable LEDs is illuminating the deep mysteries of the brain.
Researchers at the University of Illinois at Urbana-Champaign and Washington University in St. Louis developed ultrathin, flexible optoelectronic devices – including LEDs the size of individual neurons – that are lighting the way for neuroscientists in the field of optogenetics and beyond.
Led by John A. Rogers, the Swanlund professor of materials science and engineering at the U. of I., and Michael R. Bruchas, a professor of anesthesiology at Washington University, ...
Research examines effects of opioids on patients with sickle cell disease
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Researchers from Virginia Commonwealth University (VCU) sought to shed light on the biopsychosocial and spiritual effects of taking prescribed opioids to treat noncancer pain. Such questions have received little examination and impact the challenging decision of when and how to use opioids, the study authors wrote in a scientific poster presented today at the 29th Annual Meeting of the American Academy of Pain Medicine. They found that taking opioids had many and diverse consequences for patients in terms of biological, psychological, ...
Study: Pain improves during first year but mental-health problems linger
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Veterans who sustained major limb injuries during combat reported little improvement in symptoms of depression, anxiety, post-traumatic stress disorder (PTSD) and other mental-health problems up to 2 years post injury, according to research presented today. In contrast, pain showed the most improvement 3-6 months after acute hospitalization, and then leveled off after 1 year. The investigative team, led by Rollin M. Gallagher, MD, MPH, reported results during a poster session at the 29th Annual Meeting of the American Academy of ...
Experimental study suggests bone-marrow grafts show promise for some sufferers of low-back pain
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- A new study suggests that the type of bio-cellular grafts increasingly used by surgeons to repair damaged tissue may be useful for treating low-back pain (LBP). However, not all sufferers responded equally to the novel therapy. Results reported today at the 29th Annual Meeting of the American Academy of Pain Medicine ranged from complete pain relief to no improvement.
The procedure involved injecting a concentrated form of bone-marrow cellular aspirate into lumbar discs in patients with clinical and objective evidence of disc ...
High-dose opioids disturb hormones long-term, but mental and physiologic function improves
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows. The results, reported today at the 29th Annual Meeting of the American Academy of Pain Medicine, present rare data on the effects of opioids beyond 10 years. Most clinical trials that examine opioid use are of short duration, and little is known about long-term outcomes, particularly in patients who suffer from noncancer pain.
The 40 ...
Full range of treatment settings and their effects on radiofrequency heat lesion size
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Changing the parameters used to deliver radiofrequency (RF) treatment greatly affects the size of the resulting heat lesion, researchers reported today in a study expected to deliver greater precision and more treatment options in interventional pain management. Results were presented at the 29th Annual Meeting of the American Academy of Pain Medicine.
"This is the most comprehensive study of radiofrequency heat lesion size for pain management to date," said the study's lead author, Eric Cosman Jr., PhD, scientific director of ...
New techniques reduce the complications of spinal cord stimulator implant
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Two innovative techniques in the placement of an implanted spinal cord stimulator (SCS) are expected to reduce common complications at the implant site, according to new research revealed today. Results from a case series highlighted an advanced lead anchoring technique and the emerging technology of using large single-port introducers, which enable placement of multiple neurostimulation leads through a single needle-entry point.
Neurostimulation leads are used in SCS therapy for the management of chronic pain. The researchers ...
Web-based tools found to enhance recruitment and prescreening for clinical pain trials
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period. An innovative website allowed recruiters to reach out broadly to target and recruit potential subjects and to avoid many of the common difficulties of pain research, according to results presented today at the 29th Annual Meeting of the American Academy of Pain Medicine.
Research is important to establish which therapies are safe ...
Research shows promise for microwave ablation (MWA) to relieve painful bone and soft-tissue tumors
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- First-of-its-kind research presented today showed microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors and took less time to complete than radiofrequency ablation. Pain relief lasted over 4 months on average and up to 15 months in some patients, according to results reported at the 29th Annual Meeting of the American Academy of Pain Medicine.
Approximately 10,600 new cases of soft-tissue sarcoma and 2,570 new cases of bone sarcoma were diagnosed in the United States in 2009, according ...
Researchers measure reaction rates of second key atmospheric component
2013-04-12
LIVERMORE, Calif.— Researchers at Sandia National Laboratories' Combustion Research Facility, the University of Manchester, Bristol University, University of Southampton and Hong Kong Polytechnic have successfully measured reaction rates of a second Criegee intermediate, CH3CHOO, and proven that the reactivity of the atmospheric chemical depends strongly on which way the molecule is twisted.
The measurements will provide further insight into hydrocarbon combustion and atmospheric chemistry. A paper describing the research findings titled "Direct Measurements of Conformer-Dependent ...
LAST 30 PRESS RELEASES:
Warming temperatures impact immune performance of wild monkeys, U-M study shows
Fine particulate air pollution may play a role in adverse birth outcomes
Sea anemone study shows how animals stay ‘in shape’
KIER unveils catalyst innovations for sustainable turquoise hydrogen solutions
Bacteria ditch tags to dodge antibiotics
New insights in plant response to high temperatures and drought
Strategies for safe and equitable access to water: a catalyst for global peace and security
CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive
Disease severity staging system for NOTCH3-associated small vessel disease, including CADASIL
Satellite evidence bolsters case that climate change caused mass elephant die-off
Unique killer whale pod may have acquired special skills to hunt the world’s largest fish
Emory-led Lancet review highlights racial disparities in sudden cardiac arrest and death among athletes
A new approach to predicting malaria drug resistance
Coral adaptation unlikely to keep pace with global warming
Bioinspired droplet-based systems herald a new era in biocompatible devices
A fossil first: Scientists find 1.5-million-year-old footprints of two different species of human ancestors at same spot
The key to “climate smart” agriculture might be through its value chain
These hibernating squirrels could use a drink—but don’t feel the thirst
New footprints offer evidence of co-existing hominid species 1.5 million years ago
Moral outrage helps misinformation spread through social media
U-M, multinational team of scientists reveal structural link for initiation of protein synthesis in bacteria
New paper calls for harnessing agrifood value chains to help farmers be climate-smart
Preschool education: A key to supporting allophone children
CNIC scientists discover a key mechanism in fat cells that protects the body against energetic excess
Chemical replacement of TNT explosive more harmful to plants, study shows
Scientists reveal possible role of iron sulfides in creating life in terrestrial hot springs
Hormone therapy affects the metabolic health of transgender individuals
Survey of 12 European countries reveals the best and worst for smoke-free homes
First new treatment for asthma attacks in 50 years
Certain HRT tablets linked to increased heart disease and blood clot risk
[Press-News.org] Study finds interferon, one of the body's proteins, induces persistent viral infectionThe findings suggest a new approach to clearing infections from AIDS to hepatitis